Marshall Makes the Case for Molecular Sorting in Gastrointestinal Disease
July 3rd 2018Oncologists have been slow to introduce targeted and immune therapies into the treatment of gastrointestinal cancers, but that is changing, and poor patient survival statistics call for a continuation of this trend, according to John L. Marshall, MD.
Researchers Focus on Putting the STING Back Into Immune Response
July 3rd 2018Recently, immuno-oncologists have turned their attention to the role of the second arm of the immune response—the more rough-and-ready innate arm, which serves as the body’s frontline defense against pathogenic invaders and, it seems, cancer.
Choose the Right Organizational Model for Oncology Practice Success
July 1st 2018Many pressures on independent oncology practices have contributed to regionalization of services, in which practices merge or establish relationships with larger health systems. The forms that these larger systems have taken are diverse, but they do fall into several basic categories.
ACR and SBI Recommend Universal Breast Cancer Risk Assessment at Age 30
June 29th 2018New breast cancer screening guidelines from the American College of Radiology and Society of Breast Imaging advise all women to undergo risk assessment at age 30, followed by screening for those with a greater chance of cancer.
The Comorbidity Checklist: New Strategies Needed for Cancer Care
June 28th 2018Patients with cancer have high rates of comorbidities, but hard data are often lacking about the interaction of specific regimens with such health conditions. Experts say more inclusive clinical trials and broader use of risk assessment tools would help improve care.
ASTRO Guidelines Support Accelerated Whole Breast Radiation for Most Patients
June 28th 2018A new American Society for Radiation Oncology guideline calls for hypofractionated whole breast irradiation for patients with breast cancer regardless of age, tumor stage, and previous chemotherapy treatment.
Ovarian Cancer Incidence, Mortality Decline But Access to Care Is Not Equal
June 26th 2018Ovarian cancer incidence and mortality have declined significantly over the past few decades, but eliminating racial disparities in treatment and improving prevention and early detection could help save even more women.
Findings Set Stage for Expanded Immunotherapy Role in Bladder Cancer
June 26th 2018Researchers now are turning their attention toward earlier disease settings involving patients who are refractory to standard therapies in nonmuscle-invasive bladder cancer or who are poor candidates for surgery in muscle-invasive bladder cancer.